About
DaCapo Brainscience develops therapies aimed at halting progression of neurodegenerative diseases such as Parkinson’s Disease using an integrated target and drug discovery platform combining analytics, network biology, human iPS cells, and chemistry.
Explore DaCapo Brainscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.